N-Acetylcysteine for Adolescent Alcohol Use Disorder
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
This is a 8-week randomized, placebo-controlled trial testing the effects of N-acetylcysteine
(NAC), on a platform of weekly evidence-based brief alcohol intervention for 120 adolescents
with alcohol use disorder (AUD). The primary efficacy endpoint is reduction in alcohol use
(total standard drinks), compared between NAC and placebo groups.